Send us Feedback

BioMarin Pharmaceutical (BMRN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Income Statement    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Total Revenue 117M 124M 128M 132M 128M
Cost of Revenue 17.1M 23.6M 13.1M 26.5M 20.5M
Gross Profit 99.5M 100M 115M 105M 107M
Research & Development 73.8M 77.8M 66.2M 84.4M 83.7M
SG&A 45.2M 51.5M 46.3M 55.0M 51.0M
Amortization & Deprec 0 0 14.4M 25.8M 11.1M
Other Expenses 2.56M 1.41M -1.89M -13.4M -5.87M
Total Operating Expenses 122M 131M 125M 152M 140M
Operating Income -22.1M -30.3M -10.0M -46.4M -32.6M
Other Income 36.0K -176K 125K -1.77M -10.2M
EBIT -22.1M -30.5M -9.92M -48.2M -42.8M
Minority Interest 0 0 0 0 0
Interest Expense 1.95M 1.93M 1.84M 1.93M 1.73M
Income Before Taxes -24.0M -32.4M -11.8M -50.1M -44.5M
Income Taxes -34.0K -411K -6.40M 2.92M -4.71M
Net Income from Continuing Ops -24.0M -32.0M -5.36M -53.0M -39.8M
Income - Discontinued Ops 0 0 0 0 0
Extraordinary Items 0 0 0 0 0
Effect of Accounting Changes 0 0 0 0 0
Other Items 0 0 0 0 0
Net Income -24.0M -32.0M -5.36M -53.0M -39.8M
Preferred Dividends 0 0 0 0 0
Net Income to Common -24.0M -32.0M -5.36M -53.0M -39.8M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki